van Deursen, AM, et al.
Invasive pneumococcal disease and 7-valent pneumococcal conjugate vaccine, the Netherlands. Emerging Infectious Diseases
2012; 18: 1729–1737.
Miller, E, et al.
Herd immunity and serotype replacement 4 years after seven-valent pneumococcal conjugate vaccination in England and Wales: an observational cohort study. Lancet Infectious Diseases
2011; 11: 760–768.
Elston, JW, et al.
Increasing incidence of invasive pneumococcal disease and pneumonia despite improved vaccination uptake: surveillance in Hull and East Yorkshire, UK, 2002–2009. Epidemiology and Infection
2012; 140: 1252–1266.
Liesenborghs, L, et al.
Trends in serotype prevalence in invasive pneumococcal disease before and after infant pneumococcal vaccination in Belgium, 2002–2010. Vaccine
2013; 31: 1529–1534.
Metlay, JP, et al.
Exposure to children as a risk factor for bacteremic pneumococcal disease: changes in the post-conjugate vaccine era. Archives of Internal Medicine
2010; 170: 725–731.
Pilishvili, T, et al.
Sustained reductions in invasive pneumococcal disease in the era of conjugate vaccine. Journal of Infectious Diseases
2010; 201: 32–41.
Hak, E, Shea, KM, Jick, SS. Association of infant pneumococcal vaccination with pneumococcal pneumonia among mothers: a nested case-control study using the GPRD. Vaccine
2013; 31: 1590–1596.
van Gils, EJ, et al.
Effect of reduced-dose schedules with 7-valent pneumococcal conjugate vaccine on nasopharyngeal pneumococcal carriage in children: a randomized controlled trial. Journal of the American Medical Association
2009; 302: 159–167.
Flasche, S, et al.
Effect of pneumococcal conjugate vaccination on serotype-specific carriage and invasive disease in England: a cross-sectional study. PLoS Medicine
2011; 8: e1001017.
de Greeff, SC, et al.
Estimation of household transmission rates of pertussis and the effect of cocooning vaccination strategies on infant pertussis. Epidemiology (Cambridge, Mass.)
2012; 23: 852–860.
Brueggemann, AB, Spratt, BG. Geographic distribution and clonal diversity of Streptococcus pneumoniae serotype 1 isolates. Journal of Clinical Microbiology
2003; 41: 4966–4970.
Simell, B, et al.
The fundamental link between pneumococcal carriage and disease. Expert Review of Vaccines
2012; 11: 841–855.
Brueggemann, AB, et al.
Clonal relationships between invasive and carriage Streptococcus pneumoniae and serotype- and clone-specific differences in invasive disease potential. Journal of Infectious Diseases
2003; 187: 1424–1432.
Harboe, ZB, et al.
Temporal trends in invasive pneumococcal disease and pneumococcal serotypes over 7 decades. Clinical Infectious Diseases
2010; 50: 329–337.
Cobey, S, Lipsitch, M. Niche and neutral effects of acquired immunity permit coexistence of pneumococcal serotypes. Science (New York, NY)
2012; 335: 1376–1380.
Jansen, AG, et al.
Invasive pneumococcal disease among adults: associations among serotypes, disease characteristics, and outcome. Clinical Infectious Diseases
2009; 49: e23–9.
Weinberger, DM, et al.
Association of serotype with risk of death due to pneumococcal pneumonia: a meta-analysis. Clinical Infectious Diseases
2010; 51: 692–699.
Grau, I, et al.
Invasive pneumococcal disease in healthy adults: increase of empyema associated with the clonal-type Sweden(1)-ST306. PLoS ONE
2012; 7: e42595.